Saturday, August 21, 2010

US 7,696,182 for CorMedix of Bridgewater, NJ

CorMedix, one of the smaller pharmas of Bridgewater, NJ, obtained U.S. Patent No. 7,696,182, which claims cover the use of Neutrolin® for preventing infection and clotting in hemodialysis catheters. Neutrolin® is an antimicrobial/anticoagulant liquid, comprising taurolidine, that “locks” a patient’s chronic central venous catheter between hemodialysis sessions to keep it free of CRBI and clotting.


Post a Comment

<< Home